Beijing Cancer Center

Beijing 100142

0 studies enrolling now · 1 studies all time

What they study most

Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed